Target intelligence / Profile preview

Gastric mucosa and mucus layer

Molecular classification
Other (Biological barrier), Tissue layer, Secreted glycoproteins
01

Overview

The gastric mucosa and mucus layer represent the primary defensive barrier of the stomach against the harsh luminal environment characterized by low pH and digestive enzymes [1]. This system comprises a surface epithelial cell layer and an overlying mucus-bicarbonate barrier, which prevents autodigestion by neutralizing hydrochloric acid and inhibiting the activity of pepsin [2]. The mucus itself is a hydrated gel composed of high-molecular-weight glycoproteins, primarily MUC5AC and MUC6, which provide structural integrity and lubrication [2]. In clinical practice, this "target" is the focus of cytoprotective therapy for conditions like peptic ulcers and gastritis, where the barrier is compromised by factors such as H. pylori infection or NSAID use [1]. Drugs interacting with this layer typically work by forming a physical protective coating over lesions or by stimulating the endogenous production of mucus and bicarbonate through prostaglandin-mediated pathways [3].

Other names
Gastric mucosal barrierStomach liningGastric mucus-bicarbonate barrierGastric surface epithelium
02

Mechanism of action

Formation of a protective physical barrier (poly-anionic paste), stimulation of endogenous prostaglandin synthesis, enhancement of bicarbonate secretion, and inhibition of pepsin-mediated proteolysis [1][3].

03

Biological functions

Acid neutralizationPhysical protectionLubricationEpithelial repairPathogen exclusion
04

Disease associations

Peptic ulcer diseaseGastritisGastroesophageal reflux disease (GERD)Gastric cancerNSAID-induced mucosal injury
05

Safety considerations

Interference with the absorption of other medications (e.g., fluoroquinolones, digoxin)ConstipationAluminum accumulation in patients with renal impairmentUterine contractions (specific to misoprostol)
06

Interacting drugs

Sucralfate

5 more in the full profile.

07

Biomarkers

Mucin 5AC (MUC5AC)Mucin 6 (MUC6)Pepsinogen I/II ratioGastric pHTrefoil factor 1 (TFF1)

Beyond the preview

Go deeper on Gastric mucosa and mucus layer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric mucosa and mucus layer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call